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Abstract
The rapid evolution of influenza viruses presents difficulties in maintaining the optimal efficiency of vaccines. Amino acid
substitutions result in antigenic drift, a process whereby antisera raised in response to one virus have reduced effectiveness
against future viruses. Interestingly, while amino acid substitutions occur at a relatively constant rate, the antigenic
properties of H3 move in a discontinuous, step-wise manner. It is not clear why this punctuated evolution occurs, whether
this represents simply the fact that some substitutions affect these properties more than others, or if this is indicative of a
changing relationship between the virus and the host. In addition, the role of changing glycosylation of the haemagglutinin
in these shifts in antigenic properties is unknown. We analysed the antigenic drift of HA1 from human influenza H3 using a
model of sequence change that allows for variation in selective pressure at different locations in the sequence, as well as at
different parts of the phylogenetic tree. We detect significant changes in selective pressure that occur preferentially during
major changes in antigenic properties. Despite the large increase in glycosylation during the past 40 years, changes in
glycosylation did not correlate either with changes in antigenic properties or with significantly more rapid changes in
selective pressure. The locations that undergo changes in selective pressure are largely in places undergoing adaptive
evolution, in antigenic locations, and in locations or near locations undergoing substitutions that characterise the change in
antigenicity of the virus. Our results suggest that the relationship of the virus to the host changes with time, with the shifts
in antigenic properties representing changes in this relationship. This suggests that the virus and host immune system are
evolving different methods to counter each other. While we are able to characterise the rapid increase in glycosylation of
the haemagglutinin during time in human influenza H3, an increase not present in influenza in birds, this increase seems
unrelated to the observed changes in antigenic properties.
Citation: Blackburne BP, Hay AJ, Goldstein RA (2008) Changing Selective Pressure during Antigenic Changes in Human Influenza H3. PLoS Pathog 4(5): e1000058.
doi:10.1371/journal.ppat.1000058
Editor: Bruce Levin, Emory University, United States of America
Received September 19, 2007; Accepted April 4, 2008; Published May 2, 2008
Copyright:  2008 Blackburne et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Medical Research Council (UK), National Institute for Medical Research.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: richard.goldstein@nimr.mrc.ac.uk
Introduction
The rapid evolution of influenza viruses presents difficulties in
recognising and predicting current and future epidemiological
threats. One of the major sources of information about possible
future threats from influenza is a study of its history as an evolving
pathogen. Analysing how the virus evolves to evade the immune
response can provide insight into how the immune system has
dealt with the virus in the past and how the virus may change in
the future to evade elimination.
Modelling of influenza evolution has focused on haemagglutinin
(HA), the membrane-bound glycoprotein present on the surface of
the virus which is responsible for receptor-binding and membrane-
fusion. Sixteen different HA subtypes in influenza A have been
identified (H1 to H16) of which H1 and H3 are currently circulating
in human populations. For membrane fusion to occur, the HA
precursor (HA0) must be cleaved into two polypeptides, HA1 and
HA2, linked by a disulphide bond. Five canonical antigenic sites have
been identified on the HA1 polypeptide of H3 [1,2]. Because HA1 is
the principal target of antibody-mediated immunity [3], it has a
higher replacement rate for amino acids than HA2 [4].
The sequence evolution of HA1 results in antigenic drift as
antigenic properties change with time. Amino acid substitutions
result in changes in the ability of antibodies to neutralise the virus,
either through interfering with antibody binding or changing some
associated property (e.g. receptor binding), so that antisera raised in
response to one virus have reduced effectiveness against a future
virus [4]. The amount of this reduction can be used as a measure
of the difference between the antigenic properties of the two
viruses. Interestingly, antigenic properties of H3 move in a
discontinuous, step-wise manner [5]. For periods of two to five
years, HA1 sequence evolution has a limited effect on virus-
antibody interactions, so that antigenic drift is confined to a semi-
well-defined group of sequence variants with similar antigenic
properties, what has been referred to as an antigenic cluster.
Periodically, however, sequence change results in significant
change in antigenic properties, corresponding to a jump to a
new antigenic cluster. The correlation between genetic distance
and antigenic distance from the root cannot be explained by a
linear relationship [5].
There are two possible, not mutually-exclusive interpretations of
these irregular, punctuated changes. Firstly, it would be expected
that changes in different locations would have different impacts on
the antigenic properties, what has been described as the
‘influential sites’ model of antigenic change [6]. Some changes in
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properties, while other changes, near the antigenic or binding
sites, would be more important. A constant rate of change of the
sequence would result in punctuated changes in antigenic
properties if relatively few locations had a very large effect on
these properties [3]. (In the data analysed by Smith and co-
workers, jumps between antigenic clusters can result from a single
amino-acid substitution [5].)
Secondly, it might be that each antigenic cluster represents a
particular manner of interaction between the virus and the host,
such as nature or location of antibody binding. Changes in the
amino acids at some locations would cause jumps between
antigenic clusters, representing changes in this relationship. As a
result, the effect of subsequent amino acid changes at other
locations might be significantly different. In particular, Koelle et
al. recently performed a simulation of the effect of such context-
dependent interactions on the evolutionary dynamics of influenza,
showing that it could re-create many observed epidemiological
patterns [6].
One way to distinguish between these two possibilities is to look
at the changing patterns of selective pressure. If changes in the
antigenic cluster correspond to modifications in virus-host
interactions, we would expect there to be corresponding changes
in the selective pressure at different locations in the viral proteins.
As the relative and absolute rates of amino acid substitution at
these locations will depend upon the nature of the local selective
pressure, we might be able to observe a change in the pattern of
amino acid substitutions. These changes can be in the overall rate
of substitution as well as in the nature of the substitutions accepted.
One possible cause of these punctuated antigenic changes is the
changing glycosylation state of the haemagglutinin. There has
been a large increase in the number of predicted HA1
glycosylation sites from viruses isolated in 1968 to those circulating
at present [3,7]. It would seem possible that the addition of these
glycosylation sites represent a way for the virus to avoid the
immune response through gross changes in the protein exterior. If
these changes in glycosylation are related to changes in antigenic
properties, we might expect correlations between the changes in
glycosylation, changes in antigenic properties, and changes in the
selective pressure at various locations in the protein.
In addition to constructing phylogenetic trees, evolutionary
theory can also be applied to a wide range of problems through
hypothesis testing. These approaches can generate new insights
into the forces of evolution that are shaping the protein sequence,
and hence into the structure, function, and physiological context of
the protein itself [8]. Competing models of sequence change can
be applied to the data, and standard tools from statistics and
information theory can be used to evaluate the evidence for
specific behaviour. In this paper we are interested in addressing
specific questions regarding haemagglutinin evolution. Does the
selective pressure change during evolution, either in degree or
nature? Are the changes in selective pressure correlated with
changes in antigenic properties or changes in glycosylation?
We develop a series of increasingly-complex models for the
evolution of HA1 of human H3N2 viruses, at each stage inquiring
whether we have statistical grounds for rejecting the simpler
model. We start with a standard model where the rate of amino
acid change at all locations is modelled by a single substitution
matrix, allowing for heterogeneity of overall substitution rate
following a Gamma distribution. We then develop a so-called
‘mixture model’ where different locations in the protein follow one
of a set of possible substitution matrices, differing in overall
substitution rate as well as different propensities for the various
amino acids, but where we assume the substitution rates at any
location is constant over the evolutionary process. The next model
allows changes in the substitution rates during the evolution,
corresponding to changing selective pressure. Because our mixture
model includes substitution matrices that differ in their preference
for different amino acids, we can detect changes in the nature of
the selective pressure that do not correspond to changes in the
magnitude or sign. Finally, we consider a more complicated model
that considers that the alterations in selective pressure might
preferentially occur on branches of the evolutionary tree
corresponding either to changes in antigenic cluster or to changes
in glycosylation.
We find different substitution matrices describing different
regions of the protein, indicating a range of selective pressures. We
also find that these selective pressures change with time. More
specifically, changes in selective pressure do not seem to occur at a
constant rate throughout the tree. Rather, changes in selective
pressure are found to occur more often during major changes in
antigenic properties. This suggests that the movement between the
antigenic clusters, as observed in Smith et al. [5] corresponds to
changes in the nature of the interaction between virus and host.
The locations that undergo changes in selective pressure are
largely in places under positive selection, at or around the cluster-
difference substitutions (identified by Smith et al.), and in locations
in canonical antigenic sites. Surprisingly, we do not observe a
significant correlation between rapid changes in antigenic
properties and changes in the predicted HA glycosylation state.
Nor do we observe changes in glycosylation state during rapid
changes in antigenic properties. This indicates that changes in
glycosylation do not play a dominant role in the major changes of
antigenic properties.
Results
A phylogenetic tree was constructed for the sequences used in
the analysis of Smith et al. [5], as drawn schematically in Figure S1.
(The detailed tree is available from the authors.) The various
clusters of sequences with similar antigenic properties is notated by
the location (Hong Kong, ENgland, VIctoria, TeXas, BangKok,
SIngapore, BEijing, WUhan, SYdney, FUjian) and year of the
earliest sequence. The derived tree is similar to that derived by
Author Summary
H3N2-type influenza is responsible for widespread disease
and significant mortality. The virus evolves rapidly,
changing its antigenic properties, allowing it to escape
clearance by the immune response as well as complicating
the maintenance of vaccine effectiveness. Part of this
evolution has been the rapid increase in glycosylation, an
increase not observed either in H9 evolution in birds or in
H1 evolution in humans. It has been observed that the
antigenic properties change in a punctuated, discontinu-
ous manner. This could be either because some mutations
are more significant than others, or it could mean that the
antigenic changes correspond to adjustments in the
antagonistic relationship between virus and host. By
studying the sequence evolution of the H3 haemaggluti-
nin, we can demonstrate that the selective pressure acting
on the virus protein changes with time, and that these
changes are especially rapid during changes in antigenic
properties. This indicates that the antigenic changes
correspond to modifications in the virus–host relationship.
Surprisingly, neither the changes in selective pressure nor
the changes in antigenic properties correspond to changes
in glycosylation.
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transitions from antigenic clusters EN72 to VI75 and TX77, with
VI75 representing a dead-end, as well as transitions from SI87 to
both BE89 and BE92, with BE89 representing a dead-end.
We then applied a series of different evolutionary models to
these data, using various tests to quantify the statistical support for
the increased complexity. As described in the Methods section
below, if the models are nested (that is, the simpler model is a
special case of the more complex model), we can use the
likelihood-ratio test to determine the statistical support for
rejecting the simpler model. When the models are not nested,
we use the Akaike information criterion (AIC), which penalises
more complex models based on the number of adjustable
parameters; the best model is the one that minimises the AIC.
Choice of model and evaluation of model parameters
We developed four different evolutionary models. Model 1,
representing a standard optimised single substitution-model with
Gamma-distributed rates, when applied to the haemagglutinin
sequence data, yielded a log-likelihood of 24674.1, for
AIC=10,492.2. (The number of parameters includes 209 model
parameters and 363 adjustable branch lengths.) We then
developed a mixture-model (Model 2) where there were a number
of different substitution matrices representing different forms of
selective pressure, defined by an overall substitution rate and
different relative propensities for the various amino acids. Model 2
assumed that the selective pressure acting on every location was
constant with time throughout the evolutionary process. The
number of substitution matrices was optimised by minimising the
AIC. The best performance was obtained with a mixture-model
with four substitution matrices (271 adjustable model parameters),
which achieved a log-likelihood value of –4339.2 for a substantially
lower AIC=9,946.4. This indicates that an evolutionary model
including qualitatively-different forms of selective pressure at
different locations fits the data significantly better than a single
substitution matrix with a Gamma distribution of rates.
Allowing changes of selective pressure during the evolutionary
process (Model 3) increased the log-likelihood to 24319.8. Model
2 (no changes of selective pressure) is nested in Model 3, meaning
we can use the likelihood ratio test to demonstrate that the extra
parameters can be justified (P,10
24). We then tried a more
elaborate model (Model 4), where the branches that involved
changes of antigenic cluster had a greater amount of change of
selective pressure. This increase of one additional adjustable
parameter resulted in an increase in the log-likelihood to 24311.8,
indicating that this extra complexity is justified (P,10
24 with the
likelihood-ratio test), and that the increased rate of selective-
pressure change between antigenic clusters is statistically-signifi-
cant. We can then reject the null hypothesis that changes in
selective pressure occur independently of jumps in antigenic
properties, in favour of a model where changes in selective
pressure occur preferentially coincident with such jumps. The rate
of substitution-matrix change for the inter-cluster branches was
c=0.77; that is, the extra amount of substitution matrix (selective
pressure) changes is equivalent to what would be observed if the
branch lengths corresponding to antigenic cluster transitions were
increased by this amount.
Changes in glycosylation
We performed ancestral reconstruction, and predicted glyco-
sylation states of the various ancestral nodes. We restricted our
analysis of glycosylation sites to the sites predicted on the ancestral
nodes with probability .0.95. We did not consider changes in
glycosylation of the terminal sequences, as these might represent
deleterious mutations, cannot be associated with changes in
selective pressure with our model (as there is no sequence
evolution observed following the terminal sequence), and are
independent of changes in antigenic cluster.
Predicted glycosylation states are tabulated in Table S1. We
observe a sharp increase in the amount of predicted glycosylation
sites from 6 sites (HK68) to 11 (FU02), as shown in Figure 1.
Interestingly, there seems to be no correlation between changes in
glycosylation and major changes in antigenic properties, with no
transition between antigenic clusters corresponding to a difference
in glycosylation. Conversely, some antigenic clusters contain a
multiplicity of different glycosylation sites; WU95 viruses, for
instance, contain between 7 and 10 glycosylation sites per subunit.
This suggests that the rapid change of glycosylation is disjoint from
the major changes in antigenic properties.
We identified branches corresponding to a change in glycosyl-
ation. We then developed a substitution model (Model 5) where
the branches involving changes in glycosylation state were affected
by an additional amount of selective-pressure change. There was a
minimal change in log likelihood, indicating that there was not a
significant observed correspondence between changes in glycosyl-
ation and changes in selective pressure, given the available data
(P=0.8). We find no evidence that changes in glycosylation
correspond to significantly increased probability of changes in
selective pressure.
Evaluation of model
The results described in more detail below refer to Model 4,
unless specified otherwise.
The amino-acid preferences of the four substitution matrices
representing the four categories of selective pressure are
represented in Figure 2. The distribution of types of locations
described by the different substitution matrices is shown in
Figure 3A, while Figure 3B shows how the number of substitution
matrix changes during the evolutionary process corresponds to
various types of locations. In model 4, locations can change
HK68
TX77
VI75
EN72
BK79
BE89/
BE92
SI87
SY97
FU02
WU95
1975
5
11
1995 1985 1965 2005
6
7
8
9
10
N
u
m
b
e
r
 
o
f
 
g
l
y
c
o
s
y
l
a
t
i
o
n
 
s
i
t
e
s
Year
Figure 1. Changes in the number of glycosylation sites with
time. Clusters are indicated as block colouring. Thick red line
represents the main branch of the tree. Dates for the internal nodes
were estimated based on extrapolating a linear least-squares fit of the
acquisition time of the available sequences.
doi:10.1371/journal.ppat.1000058.g001
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process. The average rate of change between the different
substitution matrices is tabulated in Table S2.
Substitution matrices one and two, representing 34% and 46% of
all locations, respectively, are the slowest changing, with relative
amino-acid substitution rates (vk)o f0 . 2 8a n d0 . 4 6r e s p e c t i v e l y .( T h e
substitution rates are normalised sothat the substitution rate averaged
over all sites is 1.0) The preferred set of amino acids is largely
complementary between substitution matrices one and two, with
substitution matrix one having an above-average hydrophobicity
compared with substitution matrix two, although substitution matrix
one contains an abundance of asparagine and glutamic acid while
substitution matrix two has a propensity towards aromatic residues.
As would be expected, the sequence changes of buried locations are
preferentially described by the predominantly-hydrophobic substitu-
tion matrix one, while exposed locations not categorised as receptor-
binding or in the canonical antigenic sites are preferentially described
by the more hydrophilic substitution matrix two.
Substitution matrices three and four, representing 9% and 11%
of the locations in the protein, change relatively rapidly, with
relative substitution rates vk equal to 2.93 and 3.90. Substitution
matrix three is biased towards positively charged amino acids
(arginine and lysine), while substitution matrix four has a bias
towards small polar amino acids. Locations associated with the
antigenic response–locations in the canonical antigenic sites and
locations whose identity distinguishes the various antigenic clusters
[5]–are predominantly described by these matrices, and also more
likely to undergo changes in selective pressure. Loop regions are
preferentially describable by substitution matrix four, in contrast to
exposed coils. Receptor-binding sites are also more likely to
correspond to these rapidly-evolving substitution matrices, corre-
sponding to the high overlap between the receptor-binding and
canonical antigenic sites. It is also possible that changes in the virus
to prevent antibody neutralisation might involve modulating the
receptor-binding properties directly, rather than inhibiting anti-
body binding.
Table 1 shows the sites in the protein that undergo significant
changes in selective pressure during transitions between antigenic
clusters. As is shown, most of the changes occur in locations in the
canonical antigenic sites, but there does not seem to be a
 
 
Figure 2. Characteristics of the four substitution matrices. Each substitution matrix is represented by the Venn diagram of physical properties
devised by Taylor [43]. Non disulfide-bonded cysteines have been excluded from the figure, as all cysteines in HA1 are disulfide bridged. Each
substitution matrix is characterized by a relative overall substitution rate and different propensities for the various amino acids represented by
equilibrium frequencies. Amino acids in this figure are colored according to these equilibrium frequencies compared with the overall average. Blue
indicates a frequency is less than the mean, with red amino acids greater. More intense colors are proportionally further from the mean [44].
doi:10.1371/journal.ppat.1000058.g002
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Some of the locations undergoing selective pressure changes
correspond to locations of the cluster-difference amino acid
substitutions identified by Smith and co-workers [5] (the K156Q
substitution during the WU95RSY97 transition, and H75Q
during the SY97RFU02 transition), while other changes in
selective pressure occur near the cluster-difference substitutions
(e.g. location 157 near the G158E substitution during the
EN72RVI75 transition). There is evidence for a change in
selective pressure at location 124 during the TX77RBK79
transition, with a G124D cluster-difference substitution occurring
during the subsequent BK79RSI87 transition. Many changes in
selective pressure, however, occur in locations that are not directly
associated with cluster-difference substitutions. Haemagglutinin
must fulfil a number of functional requirements. Changes in
antigenic properties might be correlated with adjustments of other
properties, such as receptor binding, which could then be
associated with changes in selective pressure not directly associated
with the antigenic response. Finally, there might be compensatory
changes due to, for instance, the effect of some substitutions on
thermodynamic stability.
The locations of different substitution matrices and changes in
substitution matrix, compared with the canonical antigenic sites
and those determined as being under positive selection are
illustrated in Figures S2 and S3, respectively. We observe rapid
substitutions, as well as rapid changes of substitution matrix, in the
central exposed ‘pore’ at the top of the protein. These locations are
not identified either as being under positive selection, or as
changing during changes in antigenic property, although they are
centrally-located and surrounded by such locations. Changes
involved in cluster transitions BE92RWU95 and WU95RSY97
are shown in Figures S4 and S5, respectively.
Discussion
There is evidence of changes in selective pressure during HA
evolution. For instance, Wolf et al. recently observed transient
‘adaptive bursts’ characterised by positive selection occurring in
epitopic regions [9]. In between these bursts there is little evidence
for positive selection, and newly-emergent lineages only slowly
replace existent lineages. There has also been evidence for non-
transient shifts of selective pressure. For instance, while changes in
the 18 locations identified by Bush et al. as under positive selection
from 1983 to 1997 [10] seemed to be correlated with the
subsequent phylogenetic trajectories [11] and changes in antigenic
properties [5] during this same time period, changes in these 18
locations over a longer time-range were only weakly correlated
with changes in antigenic properties [5,12]. A study of sequence
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Figure 3. A) Log2-odds representation of the propensity of various types of locations for various substitution matrices in HA1,
indicating the log2 of the relative frequency of a given substitution matrix in each of the types of locations divided by what would
be expected at random. Substitution-matrix assignments are averaged over all of the internal nodes of the phylogenetic tree. Eight different types
of location types are considered: antigenic (‘Antigenic’), receptor binding sites (‘Binding’), non-antigenic non-binding exposed sites (‘Surface’), buried
sites (‘Buried’), sites of ‘cluster-difference’ substitutions (Smith et al. 2004) (‘Difference’), and positively-selected sites (‘+Sel’). Substitution matrices are
substitution-matrix 1 (horizontal lines), substitution-matrix 2 (stippled), substitution-matrix 3 (diagonal lines), and substitution-matrix 4 (cross-
hatched). Locations are considered buried or exposed based on whether their accessible side-chain area is larger or smaller than 10% of the areas
calculated by Ahmad et al. [44]. Positively-selected sites were based on the Maximum Likelihood analysis of Yang [45]; consistently less significant
correlations were observed when positively-selected sites identified by Bush et al. [10] were used. B) Log2-odds representation of the propensity of
various types of locations for various numbers of substitution-matrix changes. A posteriori probabilities of changes of substitution matrix over the
tree are calculated for each site. (Probabilities of substitution-matrix change less than 5% are neglected.) Sites are then assigned into one of three
categories of rate of change in selective pressure from the number of changes found: slow (white, 0–1 changes), medium (gray, 1–2 changes), and
fast (black, .2 changes). Arrows in the plot refer to log2-odds of negative infinity.
doi:10.1371/journal.ppat.1000058.g003
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involves changes in a local region, but that the location of this
region varied from transition to transition [13]. All of this suggests
that positive selection is a feature of influenza evolution, but that
the locations undergoing positive selection may change and new
antigenic sites may emerge.
As described in the introduction, the punctuated nature of the
antigenic changes can be explained if different locations had
different impacts on antigenic properties, and cluster-changes
corresponded to changes at the more critical locations. In this case,
the selective pressure might still be relatively constant or change in
a way not correlated with the changes in antigenic properties.
Alternatively, jumps in antigenic properties might represent
change in the mechanism of immune-avoidance for the virus or
changes in the antibody response. This latter alternative has been
recently simulated with an epidemiological model [6]. The
majority of substitutions occur within a cluster as populations
evolve within a set of sequences with similar antigenic properties.
These changes progress until a single or set of (rare) mutations
cause a jump to a new antigenic variant with higher fitness. This
sequence and its descendents replace the old cluster, resulting in
the collapse of the population to a new single lineage that
undergoes a new cycle of diversification. Our model provides
evidence for the second explanation, that the antigenic clusters
correspond to changing relationships in the ‘arms-race’ between
influenza and the immune system, resulting in significant changes
in selective pressure at different locations in the protein. These
changes in selective pressure are quite rapid, corresponding to the
amount of selective pressure change that would occur in a branch
of length 0.7, while the branch lengths for the transitions are on
the order of 0.01 to 0.03: this represents a 20- to 70-times increase
in the rate of changes of selective pressure.
Consistent with this model, the changes in selective pressure
occur predominantly in the canonical antigenic sites. These
changes also occur at locations occupied by different amino acids
in the different antigenic clusters [5]. It is important to note that
these are not necessarily cluster-defining changes, in that some of
these changes might have occurred independently of any changes
in antigenic properties. Still, there is a strong correlation between
sites undergoing such amino acid changes between antigenic
clusters and locations where there are corresponding changes in
selective pressure. There is also a significant tendency for changes
in selective pressure in the regions surrounding the cluster-
difference changes.
Interestingly, we cannot detect a significant increase in the rate
of substitution matrix change during changes in glycosylation. As
is clear from Figures S1 and 1, we also observe no correlation
between changes in glycosylation and changes in antigenic
clusters. None of the cluster-changing transitions involve a change
in glycosylation site; conversely, many single antigenic clusters
contain different HA with a wide range of different glycosylation
states. This result is surprising, given the experimental evidence
that glycosylation can reduce antibody binding [2,14–17],
although it is important to note that significant changes in
antigenic properties can occur within the antigenic clusters.
A similar analysis of glycosylation changes in H9 evolution in
birds, thought to represent a situation of viral ‘stasis’ in a natural
host, do not demonstrate any significant increase in glycosylation
state (data not shown). Similarly, the glycosylation state of H1 in
humans does not show a substantial increase, with the number of
glycosylation sites fluctuating between about 8 and 10 per subunit
(data not shown). The amount of glycosylation may represent a
balance between antibody shielding and other requirements such
as the need to modulate receptor affinity [18–20] and avoid the
innate immune response; increased haemagglutinin glycosylation
results in reduced virulence in mice due to virus binding by
collagenous lectins [21]. Reduced binding of influenza viruses by
this mechanism in humans might alter the balance towards
increased glycosylation. Another possible explanation is that
glycosylation-induced antigenic changes that might occur in
humans would not be detected in ferrets, and thus do not show
up in the antigenic property analysis of Smith et al. It is known, for
instance, that humans contain a significant number of antibodies
for galactose compared with ferrets [22]. It is not clear how this
would explain the absence of correlation between glycosylation
changes and changes in selective pressure.
We note that we are examining changes in the predicted, rather
than observed, glycosylation state. It is likely that a large fraction of
these locations are, in fact glycosylated. The crystal structure of
haemagglutinin from H3N2 A/Aichi/2/1968 (PDB designation
5HMG) is predicted to have six glycosylation sites per subunit,
four of which are observed in the structure [23]; the remaining two
might have been lost through protein expression, purification, or
crystallisation. Furthermore, we consider it unlikely that the
inaccuracy of the predictions is responsible for the lack of
correlation between antigenic changes and glycosylation changes,
as there is no reason to believe that there are significant numbers
of predicted glycosylation sites that change their occupancy during
changes in antigenic cluster while there are no sites that change
their predicted state. Similarly, it is difficult to imagine that there is
a correlation between undetected changes in occupancy of these
predicted sites that correspond to increased changes in selective
pressure when no such correlation is observed with changes in the
predicted sites.
We find strong support for a model where the selective pressure
changes preferentially during transitions between antigenic
clusters. This suggests that evolution of human H3 consists of
periods of amino acid variation according to a relatively constant
set of rules, interspersed with periods where the rules governing
variation change. These issues have important consequences for
Table 1. Most significant changes in selective pressure.
Locations with significant probability of a given substitution-
matrix change are tabulated.
2R44 R23 R44 R31 R2
HK68REN72 275(C) 229(D)
EN72RVI75,TX77 164 157(B)
TX77RBK79 124(A) 138(A)
214(D)
BK79RSI87 135(A)
SI87RBE89 78(E)
SI87RBE92 226(D)
BE92RWU95 275(C) 92(E)
WU95RSY97 156(B) 233
SY97RFU02 25 92(E) 222
75(E)
225
The magnitude of the probability of a change are given as 0.3 to 0.4 (italics), 0.4
to 0.5 (normal), and 0.5 and above (bold). Because it is difficult to separate the
transitions from EN72 to VI75 and TX77, the transition between these three
states are considered a single transition. Antigenic region (where appropriate) is
indicated.
doi:10.1371/journal.ppat.1000058.t001
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different locations in the protein are relatively constant, we could
directly extrapolate future changes from past changes, an
assumption explicit in previous analyses [11]. If, however, changes
in antigenic properties are associated with changes in virus-
immune system interactions, we might have to model changes in
this relationship in order to perform reasonable extrapolations, as
important sequence changes during one interval of antigenic drift
might not be the same as ones that are important during other
intervals. In addition to modelling how amino acids change during
time, we also may need to develop models for how the selective
pressure changes. These results also suggest that the notion of
canonical ‘antigenic sites’ might be overly simplistic. It appears
that there are a wide range of different locations with different
propensities towards antibody recognition, and that the specific
haemagglutinin locations so targeted may change with time. If so,
the distinction between antigenic and non-antigenic sites may be
subtle and time-dependent.
Methods
Evolutionary models
As described above, we develop a series of increasingly complex
models. Each increase in complexity, if justified by the data,
demonstrates a simplifying assumption that can be rejected,
providing increased understanding of the nature of the evolution-
ary process in influenza.
Early simple evolutionary models, that assume that the rate of
substitutions at all locations in all proteins at all times followed the
same substitution matrix, have been gradually supplemented by
mixture models that allow differences in the absolute substitution
rates [24], relative substitution rates at different locations [25–28],
and differences in the substitution rates at different times [29,30].
Each component of the mixture model, represented by a distinct
substitution matrix, reflects a different degree or form of selective
pressure. In the simplest models (such as Gamma-distributed rate
classes), we can consider different components as having different
magnitudes of selective pressure, resulting in different absolute
substitution rates. In the mixture models considered here, we allow
for differences in the magnitude of the selective pressure as well as
differences in the preferences for the different types of locations for
the various amino acids. For instance, one component may model
the inside of the protein, and so have a bias towards hydrophobic
amino acids.
Details of the various models are described in Protocol S1. (For
an overview of standard approaches to evolutionary modelling, see
e.g. [31].) Model 1 involves a standard single substitution matrix
with Gamma-distributed rate variation [24]. In Model 2, we
consider that different locations in the protein follow, or ‘are
assigned’, to one of a number of different possible substitution
matrices [25–28]. We do not initially know which sites belong to
which substitution matrix. Instead, each substitution matrix k has a
specified a priori probability P(k) of representing any given site in
the protein at any time. (As all sites must belong to some
substitution matrix,
P
k
P(k)~1). The different substitution
matrices are characterised by an overall substitution rate nk, the
relative frequencies for the twenty diverse amino acids {pi,k}, and a
symmetric rate parameter matrix Si,j (Si,j=Sj,i) that is optimised over
the entire dataset and is the same for all substitution matrices. The
overall substitution rates are normalised so
P
k
P(k)nk~1. Model 3
includes a rate at which a substitution matrix describing any given
location can change to another during the evolutionary time,
representing variations in the selective pressure on the protein over
time. The various parameters for the substitution matrix model
without changes in selective pressure are {Sij, P(k), nk, pi,k}.
Allowing changes in substitution matrix adds {Zkl}, a new
symmetric matrix (Zk,l=Zl,k) adding an additional Nk (Nk21)/2
parameters for Nk substitution matrices.
Models 4 and 5 consider the possibility that the rate of change of
selective pressure, that is, the rate at which a single location
changes from one substitution matrix to another, might depend
upon the specific branch of the tree, depending, for instance,
according to whether that branch involved a change in antigenic
properties (Model 4) or glycosylation state (Model 5). In these
cases, we consider a model where these specific branches are
subject to an additional substitution-model change matrix which
only includes substitution matrix change but no additional changes
of amino acid. We can then use the likelihood ratio test to see if the
resulting improvement in the log likelihood justifies the addition of
this additional parameter.
Data and adjustment of model parameters
To evaluate the models we have used the dataset of Smith et. al.
[5] which contains 254 Human H3 HA1 sequences sampled from
1968 to 2003. An avian H3 sequence (A/Duck/Hokkaido/33/80,
M16739) was used as an outgroup to root the tree. Sequences were
extracted from the Influenza Sequence Database [32]. The
Maximum Likelihood phylogenetic tree was derived using
PHYML [33] with the WAG substitution model [34] and a
Gamma-distributed rate [35]. Various parts of the tree were
assigned to different antigenic clusters according to the designa-
tions of Smith et al [5]. The listings of these antigenic clusters as
well as the abbreviations used in the text are in the legend for
Figure 1. After the computation of the phylogenetic tree, the
parameters of the model were optimised to maximise the log-
likelihood, using software available from the authors.
The probability of the different substitution matrices and amino
acids at each location in the protein for each ancestral state were
calculated using standard maximum-likelihood ancestral recon-
struction methods [36,37], as were the probability of changes in
selection pressure.
Ancestral glycosylation states were determined by searching for
locations containing the sequence Asn-Xaa-Ser/Thr with proba-
bility .0.95. Homology models of a representative set of ML
ancestral sequences were made with SwissModel [38] based on the
1MQN structure [39]. When glycosylation states were predicted
by the GlyProt server [40], all potential locations were predicted to
be glycosylated.
Model choice
We are often confronted with the choice of one model or
another, of varying degrees of complexity and resulting fit to the
sequence data. The relative fit of two different models is quantified
by the ratio of their likelihoods (that is, the probability that the
observed data would be generated by the model), or equivalently,
the magnitude of the change in log-likelihood. In some cases, these
models are ‘nested’, that is, one model (A) is a restricted form of
model (B), in which case we can use the likelihood ratio test to see
if the added complexity is justified by the resulting increase in log-
likelihood [41]. We cannot use the likelihood ratio test to evaluate
the performance of non-nested models. Instead, we use the Akaike
Information Criterion (AIC) [42], which is defined as
AIC=2Np22L, where Np is the number of adjustable parameters
and L is the log-likelihood. The preferred model is that which
minimises the resulting AIC. According to this criterion, a more
complex model is only justified when it causes an increase in the
log likelihood greater than the number of additional parameters.
Changing Selective Pressure in Human Influenza
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Table S1 Rate of change of substitution matrix. Average rates of
substitution-matrix change are represented, given by
SQkl
ii Ti~
X
i pk
i Qkl
ii .
Found at: doi:10.1371/journal.ppat.1000058.s001 (59 KB DOC)
Table S2 Glycosylated locations for the various antigenic
clusters. + refers to locations that are glycosylated in all ancestral
nodes in the cluster, while # indicates a location that is
glycosylated in some fraction of the nodes.
Found at: doi:10.1371/journal.ppat.1000058.s002 (39 KB DOC)
Figure S1 Characteristics Figure 1: Phylogenetic tree of
influenza H3 HA1 sequences. Regions of the tree are colour-
coded and labelled according to their antigenic cluster, as defined
in (Smith et al. 2004a); labels represent the location (Hong Kong
(HK), England (EN), Victoria (VI), Texas (TX), Bangkok (BK),
Sichuan (SI), Beijing (BE), Wuhan (WU), Sydney (SY), Fujian
(FU)) and year of the first identification. Changes in glycosylation
are represented by red lines. Note that no changes of antigenic
cluster correspond to changes in glycosylation.
Found at: doi:10.1371/journal.ppat.1000058.s003 (1763 KB TIF)
Figure S2 The mean substitution matrix (a) and number of
substitution-matrix changes (b) are shown on top and side
projections of a filled-sphere representation of the HA structure
1MQN [1]. Left) The mean posterior distribution of substitution
matrices for each node in the tree is used to find the assignment of
substitution matrix for each location. Substitution-matrix assign-
ment is indicated by amino-acid color. The first two (slowest)
substitution matrices are shown in white. Substitution-matrix three
is given in green, and four in red. Where assignment is
indeterminate (i.e. the posterior probabilities are spread between
the substitution matrices) this is indicated by mixing of the
appropriate colors. The unmodeled HA2 chain is shown in grey.
Bold black lines around an amino acid indicate that the location is
present in one of the five canonical antigenic sites. Right)The total
number of substitution-matrix changes is calculated for each
location over the entire tree and is shown by coloring each amino
acid an appropriate shade of red: from white (no changes) to dark
red (many changes). Black lines around an amino acid indicate
that the location is antigenic.
Found at: doi:10.1371/journal.ppat.1000058.s004 (15204 KBTIF)
Figure S3 The mean substitution matrix (Left) and number of
substitution-matrix changes (Right) are shown on 1MQN. Color
schemes are as Figure S3. Black lines indicate that a site is
predicted to be positively selected [2]. The positively selected sites
were determined from a dataset published in 1999, however
removal of all nodes from the tree after 1998 has a negligible effect
on the mean substitution-matrix or mean number of substitution-
matrix changes.
Found at: doi:10.1371/journal.ppat.1000058.s005 (17045 KB
TIF)
Figure S4 Left) The substitution-matrix assignments for the
node before the TX77RBK79 transition are plotted on the HA
structure 1MQN. Colors are as Figure S3. Centre) We calculate
the probability of each possible change in substitution matrix for
each site along the branch corresponding to the TX77RBK79.
These are indicated on the 1MQN structure by mixing the
appropriate colors. Green and red indicate changes towards
substitution matrices three and four respectively. Blue indicates a
change towards substitution matrices one and two. White sites are
unchanging. Intensity of color indicates the magnitude of the
change, and colors are mixed if more than one change is taking
place. Amino acids labeled with black edges are those designated
as cluster-difference mutations for TX77RBK79 by Smith et al.
[3]. Right) The substitution matrix assignments for the node after
the TX77RBK79 transition. Colors are as Figure 4.
Found at: doi:10.1371/journal.ppat.1000058.s006 (13815 KB
TIF)
Figure S5 Left) The substitution-matrix assignments for the
node before the WU95RSY97 transition are plotted on the HA
structure 1MQN. Colors are as Figure S3. Center) Transitions
between substitution matrices along the WU95-.SY97 transition
are marked in color as in Figure S-5(Center). Right) The
substitution-matrix assignments for the node after the
WU95RSY97 transition. Amino acids labeled with black edges
are those designated as cluster-difference mutations for WU95-
.SY97 by Smith et al. [3].
Found at: doi:10.1371/journal.ppat.1000058.s007 (12925 KB
TIF)
Protocol S1 Methods: Evolutionary models
Found at: doi:10.1371/journal.ppat.1000058.s008 (52 KB DOC)
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